CCR8 and neoplasm: Given that intratumoral Tregs have been shown to express CCR8133, another approach is to consider the Fc-optimized anti-CCR8 antibody, which was shown in murine models to selectively deplete intratumoral Tregs and not peripheral Tregs, resulting in impaired tumor growth132,133.